GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yifeng Pharmacy Chain Co Ltd (SHSE:603939) » Definitions » Piotroski F-Score

Yifeng Pharmacy Chain Co (SHSE:603939) Piotroski F-Score : 4 (As of May. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Yifeng Pharmacy Chain Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Yifeng Pharmacy Chain Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Yifeng Pharmacy Chain Co's Piotroski F-Score or its related term are showing as below:

SHSE:603939' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 9
Current: 4

During the past 13 years, the highest Piotroski F-Score of Yifeng Pharmacy Chain Co was 9. The lowest was 3. And the median was 5.


Yifeng Pharmacy Chain Co Piotroski F-Score Historical Data

The historical data trend for Yifeng Pharmacy Chain Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yifeng Pharmacy Chain Co Piotroski F-Score Chart

Yifeng Pharmacy Chain Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 5.00 5.00 7.00 4.00

Yifeng Pharmacy Chain Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 7.00 4.00 4.00

Competitive Comparison of Yifeng Pharmacy Chain Co's Piotroski F-Score

For the Pharmaceutical Retailers subindustry, Yifeng Pharmacy Chain Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yifeng Pharmacy Chain Co's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yifeng Pharmacy Chain Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Yifeng Pharmacy Chain Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was 368.676 + 294.03 + 412.801 + 406.753 = ¥1,482 Mil.
Cash Flow from Operations was 118.887 + 1474.159 + 1741.849 + 650.107 = ¥3,985 Mil.
Revenue was 5440.51 + 5181.484 + 6700.18 + 5970.923 = ¥23,293 Mil.
Gross Profit was 2193.137 + 2001.656 + 2347.148 + 2343.338 = ¥8,885 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(21399.379 + 21089.323 + 21935.279 + 24136.539 + 26161.824) / 5 = ¥22944.4688 Mil.
Total Assets at the begining of this year (Mar23) was ¥21,399 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,933 Mil.
Total Current Assets was ¥13,949 Mil.
Total Current Liabilities was ¥11,089 Mil.
Net Income was 304.197 + 247.174 + 438.242 + 336.477 = ¥1,326 Mil.

Revenue was 4601.539 + 4597.604 + 6538.758 + 5266.053 = ¥21,004 Mil.
Gross Profit was 1877.26 + 1887.452 + 2397.484 + 2088.688 = ¥8,251 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(17300.656 + 17844.9 + 19053.207 + 21036.024 + 21399.379) / 5 = ¥19326.8332 Mil.
Total Assets at the begining of last year (Mar22) was ¥17,301 Mil.
Long-Term Debt & Capital Lease Obligation was ¥2,036 Mil.
Total Current Assets was ¥10,457 Mil.
Total Current Liabilities was ¥9,636 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Yifeng Pharmacy Chain Co's current Net Income (TTM) was 1,482. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Yifeng Pharmacy Chain Co's current Cash Flow from Operations (TTM) was 3,985. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=1482.26/21399.379
=0.0692665

ROA (Last Year)=Net Income/Total Assets (Mar22)
=1326.09/17300.656
=0.07664969

Yifeng Pharmacy Chain Co's return on assets of this year was 0.0692665. Yifeng Pharmacy Chain Co's return on assets of last year was 0.07664969. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Yifeng Pharmacy Chain Co's current Net Income (TTM) was 1,482. Yifeng Pharmacy Chain Co's current Cash Flow from Operations (TTM) was 3,985. ==> 3,985 > 1,482 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=3933.123/22944.4688
=0.17141922

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=2036.262/19326.8332
=0.10535932

Yifeng Pharmacy Chain Co's gearing of this year was 0.17141922. Yifeng Pharmacy Chain Co's gearing of last year was 0.10535932. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=13948.585/11088.642
=1.25791643

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=10456.653/9635.983
=1.08516723

Yifeng Pharmacy Chain Co's current ratio of this year was 1.25791643. Yifeng Pharmacy Chain Co's current ratio of last year was 1.08516723. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Yifeng Pharmacy Chain Co's number of shares in issue this year was 1016.883. Yifeng Pharmacy Chain Co's number of shares in issue last year was 989.639. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=8885.279/23293.097
=0.38145546

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=8250.884/21003.954
=0.39282527

Yifeng Pharmacy Chain Co's gross margin of this year was 0.38145546. Yifeng Pharmacy Chain Co's gross margin of last year was 0.39282527. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=23293.097/21399.379
=1.08849406

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=21003.954/17300.656
=1.21405535

Yifeng Pharmacy Chain Co's asset turnover of this year was 1.08849406. Yifeng Pharmacy Chain Co's asset turnover of last year was 1.21405535. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+1+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Yifeng Pharmacy Chain Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Yifeng Pharmacy Chain Co  (SHSE:603939) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Yifeng Pharmacy Chain Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Yifeng Pharmacy Chain Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Yifeng Pharmacy Chain Co (SHSE:603939) Business Description

Traded in Other Exchanges
N/A
Address
No. 68 Yifeng Medicine Park, Hunan Lugu High-tech Zone, Jinzhou Road, Changsha, CHN, 410000
Yifeng Pharmacy Chain Co Ltd operates as a chain of retail stores that specialize in pharmaceutical and over-the-counter remedies and personal care products in China. Its products include pharmaceuticals, medical equipment, health products, health food, personal care products also maternal and child products. Its stores offer various drugs; gynecological medicines; pediatric medicines: male medicines; contact lenses; Chinese products; nutrition and instruments; and personal care products.

Yifeng Pharmacy Chain Co (SHSE:603939) Headlines

No Headlines